Treatment of Genetic Diseases: Murine Mps Vii as A Model

Sands, Mark S.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Postdoctoral Individual National Research Service Award (F32)
• Project #: 5F32DK008546-02
• Application #: 3037404
• Study Section: Biological Sciences 2 (BIOL)
• Project Start: 1992-08-01
• Budget Start: 1992-08-01
• Budget End: 1993-06-30
• Support Year: 2
• Fiscal Year: 1992

Institution

• Name: Jackson Laboratory
• DUNS #: 042140483
• City: Bar Harbor
• State: ME
• Country: United States
• Zip Code: 04609

Publications

Sands, M S; Erway, L C; Vogler, C et al. (1995) Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Blood 86:2033-40

Sands, M S; Barker, J E; Vogler, C et al. (1993) Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 68:676-86

Sands, M S; Birkenmeier, E H (1993) A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII. Proc Natl Acad Sci U S A 90:6567-71